Effect of Anticholinergic Drug On uroflowmetry

Survey The Effect Of Anticholinergic Drug On Uroflowmetry In Patients With Benign Prostatic Hyperplasia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190928044913N1

Enrollment

Registered

2019-11-11

Start date

2019-04-21

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia. Enlarged prostate

Interventions

Intervention group: Tolterodine 1 mg every 12 hours is added for one month to patients with benign prostate enlargement who have been pre-treated tamsulin 0/4 daily.tolterodine is anticholonergic dr

Eligibility

Sex/Gender

Male

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient Whit Benign Prostatic Hyperplasia treat with a Blaker

Exclusion criteria

Exclusion criteria: Past Mediacal History of Prostatic cancer Age underb 50 years Past Medical History Prostatic surgery Past Medical History Of neurology illness History Of Use Anticholinergic In 2 Past Week

Design outcomes

Primary

Measure	Time frame
Q max in uroflowmetry. Timepoint: at begening and 1 month later. Method of measurement: uroflowmetri.	—

Secondary

Measure	Time frame
Urine rezidual. Timepoint: at beginnig and 1 month later. Method of measurement: sonography.;Prostate volume. Timepoint: at beginning and 1 month later. Method of measurement: sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhosein Zafaranian

Sabzevar University of Medical Sciences

zaferanianA91@medsab.ac.ir+98 11 3223 1465

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026